Clinical trial

Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

NCT00002889

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-05-01

PhasePHASE2

Study timeline

Study start (unknown)1997-05-01Date precision: month

Registry last updated2023-08-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

flutamideDRUG · verified · RxNorm: flutamide

goserelinDRUG · verified · RxNorm: goserelin

leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate

low-LET photon therapyRADIATION

Sponsors & collaborators

Alliance for Clinical Trials in Oncologylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

BostonMassachusetts, United States2 New YorkNew York, United States1 ChicagoIllinois, United States1 San FranciscoCalifornia, United States1 ColumbusOhio, United States1 DurhamNorth Carolina, United States1 Washington D.C.District of Columbia, United States1 CharlestonSouth Carolina, United States1 Winston-SalemNorth Carolina, United States1 BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00002889 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.